Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals von Elsallab, Magdi, Bravery, Christopher A., Kurtz, Andreas, Abou-El-Enein, Mohamed

Volltext

Do Human Leukocyte Antigen-Typed Cellular Therapeutics Based on Induced Pluripotent Stem Cells Make Commercial Sense? von Bravery, Christopher A.

Volltext

Editorial to Theme Issue on Cell Based Therapeutics von Hoogendoorn, Karin H., Bravery, Christopher A.

Volltext

Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry von Bravery, Christopher A, Carmen, Jessica, Fong, Timothy, Oprea, Wanda, Hoogendoorn, Karin H, Woda, Juliana, Burger, Scott R, Rowley, Jon A, Bonyhadi, Mark L, Van't Hof, Wouter

Volltext

Increasing renal mass improves survival in anephric rats following metanephros transplantation von Marshall, Damian, Dilworth, Mark R., Clancy, Marc, Bravery, Christopher A., Ashton, Nick

Volltext

Reference materials for cellular therapeutics von Bravery, Christopher A, French, Anna

Volltext

Regulating interface science healthcare products: myths and uncertainties von Bravery, Christopher A.

Volltext

Translation and commercialization of regenerative medicines von Polak, Julia, Bravery, Christopher A., Prescott, Catherine

Volltext

Development and functional capacity of transplanted rat metanephroi von Dilworth, Mark Robert, Clancy, Marc James, Marshall, Damian, Bravery, Christopher A., Brenchley, Paul E., Ashton, Nick

Volltext

Generation of CD8 Suppressor Factor and β Chemokines, Induced by Xenogeneic Immunization, in the Prevention of Simian Immunodeficiency Virus Infection in Macaques von Wang, Yufei, Tao, Louisa, Mitchell, Elaine, Willy M. J. M. Bogers, Doyle, Carl, Bravery, Christopher A., Bergmeier, Lesley A., Kelly, Charles G., Heeney, Jonathan L., Lehner, Thomas

Volltext

Human CD154 induces activation of porcine endothelial cells and up-regulation of MHC class II expression von RUSHWORTH, Stuart A, BRAVERY, Christopher A, THOMPSON, Simon

Volltext

Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism von MENGUBAS, K, RIORDAN, F. A, BRAVERY, C. A, LEWIN, J, OWENS, D. L, MEHTA, A. B, HOFFBRAND, A. V, GITENDRA WICKREMASINGHE, R

Volltext

Herbimycin A accelerates the induction of apoptosis following etoposide treatment or γ-irradiation of bcr/abl-positive leukaemia cells von RIORDAN, F. A, BRAVERY, C. A, MENGUBAS, K, RAY, N, BORTHWICK, N. J, AKBAR, A. N, HART, S. M, HOFFBRAND, A. V, MEHTA, A. B, WICKREMASINGHE, R. G

Volltext

Experimental Physiology: Increasing renal mass improves survival in anephric rats following metanephros transplantation von Marshall, Damian, Dilworth, Mark R, Clancy, Marc, Bravery, Christopher A, Ashton, Nick

Volltext

Direct recognition of SLA- and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2 von BRAVERY, C. A, BATTEN, P, YACOUB, M. H, ROSE, M. L

Volltext

High sequence homology between human and pig CD40 with conserved binding to human CD154 von Rushworth, S A, Bravery, C A, Thompson, S

Volltext

DIRECT RECOGNITION OF SLA- AND HLA-LIKE CLASS II ANTIGENS ON PORCINE ENDOTHELIUM BY HUMAN T CELLS RESULTS IN T CELL ACTIVATION AND RELEASE OF INTERLEUKIN-2 von BRAVERY, CHRISTOPHER A., BATTEN, PUSPA, YACOUB, MAGDI H., ROSE, MARLENE L.

Volltext

Enabling Consistency in Pluripotent Stem Cell‐Derived Products for Research and Development and Clinical Applications Through Material Standards von French, Anna, Bravery, Christopher, Smith, James, Chandra, Amit, Archibald, Peter, Gold, Joseph D., Artzi, Natalie, Kim, Hae-Won, Barker, Richard W., Meissner, Alexander, Wu, Joseph C., Knowles, Jonathan C., Williams, David, García-Cardeña, Guillermo, Sipp, Doug, Oh, Steve, Loring, Jeanne F., Rao, Mahendra S., Reeve, Brock, Wall, Ivan, Carr, Andrew J., Bure, Kim, Stacey, Glyn, Karp, Jeffrey M., Snyder, Evan Y., Brindley, David A.

Volltext

Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group von Song, Hannah W., Solomon, Jennifer N., Masri, Fernanda, Mack, Amanda, Durand, Nisha, Cameau, Emmanuelle, Dianat, Noushin, Hunter, Arwen, Oh, Steve, Schoen, Brianna, Marsh, Matthew, Bravery, Christopher, Sumen, Cenk, Clarke, Dominic, Bharti, Kapil, Allickson, Julie G., Lakshmipathy, Uma

Volltext

The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns von Cuende, Natividad, Boniface, Christelle, Bravery, Christopher, Forte, Miguel, Giordano, Rosaria, Hildebrandt, Martin, Izeta, Ander, Dominici, Massimo

Volltext